Inhibition of EZH2 (Enhancer of zeste homology 2) could have restore SLFN11 expression and resensitize SCLC derived of patient‐derived xenografts to DNA damage (Gardner et al., 2017). This evidence concerns the gene SLFN11 and small cell lung carcinoma.